Contributors
malaria
MALARIA
RW, AMP, and CC conceived and planned the study. AMP and HD obtained the funding. RW (with support from AB) led all field aspects of the trial and adherence to good clinical practice. S-RP, AB, HD, AEA, and HV led the analysis to derive the hepcidin cutoff value. MWJ established the hepcidin ELISA in Keneba (The Gambia) and SS, ED, EAS, and AJ conducted the core laboratory analyses. MMG and CC conceived and conducted the malaria assays. JHC and CC conceived and conducted the bacterial analyses. LK, MW, and RW conducted the statistical analysis (with support from HV). RW, AMP, LK, and MW had access to the full cleaned and locked dataset. RW and AMP drafted the manuscript with input from all authors. All authors critiqued and approved the manuscript. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.